{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:06:12Z","timestamp":1792605972321,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-02000-0","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:59:43Z","timestamp":1785898783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IFI6 is associated with interferon activation and complement-associated immune responses in primary Sj\u00f6gren\u2019s disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Yibing","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjv","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-0478","authenticated-orcid":false,"given":"Zuoqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"crossref","unstructured":"Adang LA, D'Aiello R, Takanohashi A, Woidill S, Gavazzi F, Behrens EM, Sullivan KE, Goldbach-Mansky R, de Jesus AA, Vanderver A, Shults J (2024) IFN-signaling gene expression as a diagnostic biomarker for monogenic interferonopathies. JCI Insight 9(14):e178456","DOI":"10.1172\/jci.insight.178456"},{"issue":"8","key":"2000_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, Rocca GL, Ferro F (2024) Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(8):473\u2013491","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2000_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41584-023-01057-6","volume":"20","author":"M Beydon","year":"2024","unstructured":"Beydon M, McCoy S, Nguyen Y, Sumida T, Mariette X, Seror R (2024) Epidemiology of Sj\u00f6gren syndrome. Nat Rev Rheumatol 20(3):158\u2013169","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2000_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/1744666X.2021.1879641","volume":"17","author":"L Chatzis","year":"2021","unstructured":"Chatzis L, Vlachoyiannopoulos PG, Tzioufas AG, Goules AV (2021) New frontiers in precision medicine for Sjogren\u2019s syndrome. Expert Rev Clin Immunol 17(2):127\u2013141","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"2000_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42358-023-00304-4","volume":"63","author":"J Chen","year":"2023","unstructured":"Chen J, He Q, Yang J, Wu T, Huang Z, Zhang Y, Liao J, Zhang L, Yu X, Yao C, Luo J, Tao Q (2023) Anti-SSA\/SSB-negative primary Sj\u00f6gren\u2019s syndrome showing different clinical phenotypes: a retrospective study of 934 cases. Adv Rheumatol 63(1):21","journal-title":"Adv Rheumatol"},{"key":"2000_CR6","doi-asserted-by":"crossref","unstructured":"Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo MS (2021) The involvement of innate and adaptive immunity in the initiation and perpetuation of Sj\u00f6gren's syndrome. Int J Mol Sci 22(2):658","DOI":"10.3390\/ijms22020658"},{"key":"2000_CR7","doi-asserted-by":"crossref","unstructured":"de Oliveira FR, Fantucci MZ, Adriano L, Valim V, Cunha TM, Louzada-Junior P, Rocha EM (2018) Neurological and inflammatory manifestations in Sj\u00f6gren\u2019s syndrome: The role of the kynurenine metabolic pathway. Int J Mol Sci 19(12)","DOI":"10.3390\/ijms19123953"},{"issue":"6","key":"2000_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/rheumatology\/kes374","volume":"52","author":"J He","year":"2013","unstructured":"He J, Ding Y, Feng M, Guo J, Sun X, Zhao J, Yu D, Li Z (2013) Characteristics of Sj\u00f6gren\u2019s syndrome in rheumatoid arthritis. Rheumatology (Oxford) 52(6):1084\u20131089","journal-title":"Rheumatology (Oxford)"},{"key":"2000_CR9","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3389\/fimmu.2019.02096","volume":"10","author":"MR van der Hillen","year":"2019","unstructured":"Hillen MR, Pandit A, Blokland SLM, Hartgring SAY, Bekker CPJ, van der Heijden EHM, Servaas NH, Rossato M, Kruize AA, van Roon JAG, Radstake T (2019) Plasmacytoid DCs from patients with Sj\u00f6gren\u2019s syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production. Front Immunol 10: 2096","journal-title":"Front Immunol"},{"key":"2000_CR10","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.jtauto.2024.100248","volume":"9","author":"J Huang","year":"2024","unstructured":"Huang J, Tang J, Zhang C, Liu T, Deng Z, Liu L (2024) Single-cell transcriptomic analysis uncovers heterogeneity in the labial gland microenvironment of primary Sj\u00f6gren\u2019s syndrome. J Translational Autoimmun 9:100248","journal-title":"J Translational Autoimmun"},{"issue":"1","key":"2000_CR11","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1038\/s41467-025-63935-9","volume":"16","author":"J Inamo","year":"2025","unstructured":"Inamo J, Takeshita M, Suzuki K, Tsunoda K, Usuda S, Kuramoto J, Moody J, Hon CC, Ando Y, Sasaki T, Yoshitake K, Mitsuyama S, Asakawa S, Kanai Y, Takeuchi T, Kaneko Y (2025) Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sj\u00f6gren\u2019s disease reveals common and distinct immune activation and fibroblast-mediated inflammation. Nat Commun 16(1):8299","journal-title":"Nat Commun"},{"issue":"1","key":"2000_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13578-023-01188-z","volume":"13","author":"L Ji","year":"2023","unstructured":"Ji L, Li T, Chen H, Yang Y, Lu E, Liu J, Qiao W, Chen H (2023) The crucial regulatory role of type I interferon in inflammatory diseases. Cell Bioscience 13(1):230","journal-title":"Cell Bioscience"},{"issue":"3","key":"2000_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4081\/reumatismo.2017.1032","volume":"69","author":"MC Leone","year":"2017","unstructured":"Leone MC, Alunno A, Cafaro G, Valentini V, Marcucci E, Bartoloni E, Gerli R (2017) The clinical spectrum of primary Sj\u00f6gren\u2019s syndrome: beyond exocrine glands. Reumatismo 69(3):93\u2013100","journal-title":"Reumatismo"},{"issue":"12","key":"2000_CR15","first-page":"2069","volume":"43","author":"R Li","year":"2025","unstructured":"Li R, Jia Y, Wu X, Wang M, Deng C, Peng Y, Zhao L, Zhang W, Zhou J, Li M, Zhao Y, Zeng X, Fei Y (2025) Dysregulated plasmacytoid dendritic cells in primary Sj\u00f6gren\u2019s syndrome: normal functionality but decreased quantities. Clin Exp Rheumatol 43(12):2069\u20132081","journal-title":"Clin Exp Rheumatol"},{"key":"2000_CR14","doi-asserted-by":"publisher","first-page":"100338","DOI":"10.1016\/j.jtauto.2025.100338","volume":"12","author":"J Li","year":"2026","unstructured":"Li J, Li S, Liu W (2026) Data-driven classification of primary Sj\u00f6gren\u2019s syndrome: From cluster analysis to clinical immune phenotypes and predictive biomarkers. J Transl Autoimmun 12:100338","journal-title":"J Transl Autoimmun"},{"issue":"4","key":"2000_CR16","doi-asserted-by":"publisher","first-page":"e0173301","DOI":"10.1371\/journal.pone.0173301","volume":"12","author":"R Liu","year":"2017","unstructured":"Liu R, Gao C, Chen H, Li Y, Jin Y, Qi H (2017) Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PLoS ONE 12(4):e0173301","journal-title":"PLoS ONE"},{"issue":"7","key":"2000_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39629","volume":"68","author":"NI Maria","year":"2016","unstructured":"Maria NI, van Helden-Meeuwsen CG, Brkic Z, Paulissen SM, Steenwijk EC, Dalm VA, van Daele PL, van Hagen PM, Kroese FG, van Roon JA, Harkin A, Dik WA, Drexhage HA, Lubberts E, Versnel MA (2016) Association of increased treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 68(7):1688\u20131699","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"2000_CR18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA (2018) Primary Sj\u00f6gren\u2019s Syndrome. N Engl J Med 378(10):931\u2013939","journal-title":"N Engl J Med"},{"issue":"3","key":"2000_CR19","first-page":"185","volume":"37","author":"N Marketos","year":"2019","unstructured":"Marketos N, Cinoku I, Rapti A, Mavragani CP (2019) Type I interferon signature in Sj\u00f6gren\u2019s syndrome: pathophysiological and clinical implications. Clin Exp Rheumatol 37(3):185\u2013191","journal-title":"Clin Exp Rheumatol"},{"key":"2000_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","volume":"9","author":"CP Mavragani","year":"2014","unstructured":"Mavragani CP, Moutsopoulos HM (2014) Sj\u00f6gren\u2019s syndrome. Annu Rev Pathol 9:273\u2013285","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2000_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, Indiveri F, Puppo F (2022) Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med 22(1):9\u201325","journal-title":"Clin Exp Med"},{"key":"2000_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP (2015) Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J Autoimmun 63:47\u201358","journal-title":"J Autoimmun"},{"issue":"1","key":"2000_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.0105-2896.2009.00881.x","volume":"234","author":"M Swiecki","year":"2010","unstructured":"Swiecki M, Colonna M (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 234(1):142\u2013162","journal-title":"Immunol Rev"},{"issue":"5","key":"2000_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","volume":"19","author":"GE Thorlacius","year":"2023","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M (2023) Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat Rev Rheumatol 19(5):288\u2013306","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"2000_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Pringle S, Bootsma H, Kroese FGM (2021) Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol 17(6):333\u2013348","journal-title":"Nat Rev Rheumatol"},{"key":"2000_CR26","doi-asserted-by":"publisher","first-page":"1105309","DOI":"10.3389\/fimmu.2023.1105309","volume":"14","author":"L Villamayor","year":"2023","unstructured":"Villamayor L, Rivero V, L\u00f3pez-Garc\u00eda D, Topham DJ, Mart\u00ednez-Sobrido L, Nogales A, DeDiego ML (2023) Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation. Front Immunol 14:1105309","journal-title":"Front Immunol"},{"issue":"2","key":"2000_CR27","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/rheumatology\/keab367","volume":"61","author":"L Wei","year":"2022","unstructured":"Wei L, Zhifei X, Xiaoran N, Meilu L, Yang L, Yixuan L, Xiuying R, Yashuang S, Jingjing C, Shaoying G, Liu Y, Lijun S, Fengxiao Z, Wen Z (2022) Patients with early-onset primary Sj\u00f6gren\u2019s syndrome have distinctive clinical manifestations and circulating lymphocyte profiles. Rheumatology (Oxford) 61(2):597\u2013605","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2000_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6(5):359\u2013362","journal-title":"Nat Methods"},{"key":"2000_CR29","doi-asserted-by":"crossref","unstructured":"Zheng Q, Liu L, Wang B, He Y, Zhang M, Shi G (2023) Phosphorylated signal transducer and activator of transcription proteins 1 in salivary glandular tissue: an important histological marker for diagnosis of primary Sj\u00f6gren's syndrome. RMD Open 9(1):e002694.","DOI":"10.1136\/rmdopen-2022-002694"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02000-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:59:47Z","timestamp":1785898787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-02000-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02000-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Qilu Hospital, Shandong University (Approval No. QLCR20240697). Written informed consent was obtained from all participants prior to enrollment.","order":1,"name":"Ethics","label":"Ethics approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"217"}}